2 completed, 1 withdrawn. 1 Not applicable, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Completed 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Withdrawn 1 |
Follow Stage I Prostate Adenocarcinoma: new trials by email Literature Review of Stage I Prostate Adenocarcinoma trials Research Report on Stage I Prostate Adenocarcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Bicalutamide and Raloxifene Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery Bicalutamide, Laboratory Biomarker Analysis, Questionnaire Administration - Stage I Prostate Adenocarcinoma, Stage II Prostate Adenocarcinoma | Phase 2 | Withdrawn | Mayo Clinic | 2017-06-27 | 2019-01-22 | |
| Stereotactic Body Radiation Therapy With Boost Using Urethral-Sparing Intensity-Modulated Radiation Therapy Planning in Treating Patients With Prostate Cancer Radiation Therapy Treatment Planning and Simulation, SBRT - Stage I Prostate Adenocarcinoma, Stage II Prostate Adenocarcinoma | Not applicable | Completed | University of Wisconsin, Madison | 115 | 2015-07-24 | 2026-10-13 |
| PLX3397, Radiation Therapy, and Antihormone Therapy in Treating Patients With Intermediate- or High-Risk Prostate Cancer Antiandrogen Therapy, Laboratory Biomarker Analysis, Multitargeted Tyrosine Kinase Inhibitor PLX3397 - Stage I Prostate Adenocarcinoma, Stage II Prostate Adenocarcinoma | Phase 1 | Completed | Barbara Ann Karmanos Cancer Institute | 8 | 2015-06-01 | 2020-10-06 |
Androgen Antagonists (1) · Radiation (1) · Radiosurgery (1) · Radiotherapy (1) · Raloxifene Hydrochloride (1) · bicalutamide (1) · pexidartinib (1)
Barbara Ann Karmanos Cancer Institute (1) · Mayo Clinic (1) · University of Wisconsin, Madison (1)
United States (2)
Elisabeth I. Heath, M.D. (1) · Erik Castle (1) · Zachary Morris (1)
P30CA015083 (1), P30CA022453 (1)